FDA Issues Drug Safety Alert on Severe Lung Inflammation Due to Treatment with CDK4/6 Inhibitors for Breast Cancer
1 Oct, 2019 | 00:36h | UTCCommentary: FDA Issues Drug Safety Communication on Lung Inflammation Due to Treatment With CDK4/6 Inhibitors – The ASCO Post (free)